Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report

Characteristic morphological changes in anti-VEGF therapy induced glomerular microangiopathy

(2018) Frederick Pfister et al.   HISTOPATHOLOGY

A Case of Dasatinib-Induced Nephrotic Syndrome in a Child with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

(2016) Young Tae Lim et al.   YONSEI MEDICAL JOURNAL

Dasatinib-induced nephrotic syndrome

(2015) Taichi Hirano et al.   LEUKEMIA & LYMPHOMA

Dasatinib-Induced Nephrotic-Range Proteinuria

(2013) Eric Wallace et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Vascular endothelial growth factor and the kidney

(2013) Andrew Advani   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Sunitinib-induced nephrotic syndrome and irreversible renal dysfunction

(2011) Daiei Takahashi et al.   Clinical and Experimental Nephrology

Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors

(2011) J. C. Montero et al.   CLINICAL CANCER RESEARCH

Fibrillary Glomerulonephritis: A Report of 66 Cases from a Single Institution

(2011) S. H. Nasr et al.   Clinical Journal of the American Society of Nephrology

Antitumor Activity of Targeting Src Kinases in Endothelial and Myeloid Cell Compartments of the Tumor Microenvironment

(2010) W. Liang et al.   CLINICAL CANCER RESEARCH

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

(2009) G. D. Demetri et al.   CLINICAL CANCER RESEARCH

Urine Podocyte mRNAs Mark Progression of Renal Disease

(2009) Y. Sato et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY